대한한방소아과학회지 (The Journal of Pediatrics of Korean Medicine)

  • 제28권3호
  • /
  • Pages.17-30
  • /
  • 2014
  • /
  • 1226-8038(pISSN)
  • /
  • 2287-9463(eISSN)
대한한방소아과학회 (The Association of Korean Oriental Pediatrics)
권호 표지
DOI QR코드

DOI QR Code

영유아 아토피피부염 환자 69명의 한의학적 치료효과에 대한 후향적 연구

Retrospective Study about the Effectiveness of a Korean Medicine Treatment on 69 Infant and Young Child Atopic Dermatitis Patients

  • 투고 : 2014.07.25
  • 심사 : 2014.08.11
  • 발행 : 2014.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives The purpose of this study is to report the effectiveness of Korean medicine treatment on 69 infant and young child atopic dermatitis patients. Methods 69 infants and young child atopic dermatitis patients who had visited oriental medical clinics from 2011.1.9 to 2012.1.31 were studied. All of them were continually treated for 3 to 9 months, and were analyzed by Objective SCORAD Index (OSI). A detailed analysis of OSI was done according to gender, age, using of topical steroid ointment, family history of atopic disease, treatment period, and intensity. Results 1. Male and female percentage of the study group was 56.5%: 43.5%. The average period of treatment was 6.09 months. 71.0% used topical steroid ointment, and 65.2% had family history of atopic disease. 2. The average period of treatment was significantly longer in patients who used topical steroid ointment, or who had family history of atopic disease. 3. 95.7% of total patients reported decrease in OSI score at the final visit. OSI was significantly lowered after 3, 6, and 9 months of treatment. The longer period of treatment, the lower average post-treatment OSI. 4. 85.5% of the study group had severe dermatitis, and 14.5% was moderate case based on the OSI intensity assessment at initial visit. These percentages got changed at the final visit as 34.8% of severe, 58.0% of moderate, and 7.2% of mild cases. The average treatment period of patients who were diagnosed as severe at the initial visit was 6.18 months, and their final OSI improvement rate was 39.58%. 58% of them were improved to be mild or moderate at the final visit. Conclusion The Korean medicine treatment is effective in treating infant and young child atopic dermatitis patients. There was significant decrease in OSI score after 3, 6, and 9 months of treatment. The difference increase with the treatment period.

키워드

참고문헌

  1. Bohme M, Svensson A, Kull I, Nordvall SL, Wahlgren CF. Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study. Acta Derm Venereol. 2001;81(3):193-7. https://doi.org/10.1080/000155501750376294
  2. Pyun BY. Risk factors of atopic dermatitis in young children. Pediatr Allergy Respir Dis (Korea). 2005;15(3):235-7.
  3. Clark RA, Kristal L. Atopic dermatitis. In: Sams WM, Lynch PJ, eds. Principles and practice of dermatology. New York: Churchill Linvingston. 1996:403-18.
  4. Ministry of Health and Welfare & Korea Center for Disease Control and Prevention (2010): Korea National Health and Nutrition Examination Survey (KNHANES IV-3).
  5. American Academy of Pediatrics, Committee on Children With Disabilities. Developmental surveillance and screening of infants and young children. Pediatrics. 2001;108(1):192-6. https://doi.org/10.1542/peds.108.1.192
  6. Choue RW, Lee EY, Ryu KA, Yim JE, Lee HB, Oh JW. Effects of types of formulas on the clinical symptoms, nutritional status and immune markers in infants with atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2007;27(1):33-42.
  7. Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child. 1993;69(6):670-6. https://doi.org/10.1136/adc.69.6.670
  8. Park CK, Park CW, Lee CH. Quality of life and the family impact of atopic dermatitis in children. Korean J Dermatol. 2007;45(5):429-38
  9. Watson W, Kapur S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2011;7(suppl 1):S4. https://doi.org/10.1186/1710-1492-7-S1-S4
  10. Gallant C, Kenny P. Oral glucocorticoids and their complications. A review. J Am Acad Dermatol. 1986;14(2 pt 1):161-77. https://doi.org/10.1016/S0190-9622(86)70018-2
  11. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, Allen BR, Camp RD. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet. 1991;338(8760):137-40. https://doi.org/10.1016/0140-6736(91)90134-B
  12. Kim TY. Treatment of atopic dermatitis: an update and review of the literature. Pediatr Allergy Respir Dis (Korea). 2009;19(3):209-19.
  13. Seo MS, Kim KH. The study on atopic dermatitis papers published in the journal of korean oriental ophthalmology & otolaryngology & dermatology. J Korean Orient Med Ophtahlmol Otolaryngol Dermatol. 2009;22(3):108-21.
  14. Korean Dermatological Association Textbook Compilation Committee. 5th Edition Dermatology. Seoul: Ryomoongak P Co. 2008:170.
  15. Shin MR, Oh JA, Lee DN. 6 Cases of atopic dermatitis children patients for hospitalization program. J Pediatr Korean Med. 2014;28(2):40-55. https://doi.org/10.7778/jpkm.2014.28.2.040
  16. Ko MJ, Baek JH. A clinical study on the effect of Hwangryunhaedock-tang on atopic dermatitis. J Korean Orient Pediatr. 2012;26(4):51-60. https://doi.org/10.7778/jpkm.2012.26.4.051
  17. Jo MS, Han JK, Kim YH. The use of oriental medicine for pediatric outpatients with atopic dermatitis. J Pediatr Korean Med. 2011;25(2):8-14. https://doi.org/10.7778/jpkm.2011.25.2.008
  18. Yu HY, Kim KB, Min SY, Kim JH. Case study of the effects of Saenghyeoryunbueum on atopic dermatitis. J Pediatr Korean Med. 2008;22(1):35-48.
  19. Song HJ, Han JK, Kim YH. A clinical study on the treatment of atopic dermatitis by using Kami-chungsimyeunjatang. J Pediatr Korean Med. 2007;21(3):21-31.
  20. Park YL, Kim HD, Kim KH, Kim MN, Kim JW, Ro YS, Park CW, Lee KH, Lee AY, Cho SH, Choi JH. Report from ADRG: A study on the diagnostic criteria of korean atopic dermatitis. Korean J Dermatol. 2006;44(6):659-63.
  21. Stalder JF, Taieb A. Severity scoring of atopic dermatitis: the SCORAD index. consensus report of the european task force on atopic dermatitis. Dermatol. 1993;186(1):23-31. https://doi.org/10.1159/000247298
  22. Kim KB, Kim DG, Kim YH, Kim JH, Min SY, Park EJ, Baek JH, Yu SA, Lee SY, Lee JY, Lee HJ, Chang GT, Chai JW, Han YJ, Han JK. Hanbangsoacheongsonyeonuihak. Seoul: Ui Sung Dang Publishing Co. 2010:185-7, 751.
  23. Wu Q. Yi Zong Jin Jian, Vol 3. Beijing: Ren Min Wei Sheng Publishing Co. 1982:443-4, 451-2.
  24. Chao YF. Chao Shi Zhu Bing Yuan Hou Lun. Shanghai: Jiwenshuju. 1965:505.
  25. Xuekai. Baoyingquanshu. Taibei: Xinwenfengchubangongsi. 1979:252-6.
  26. Lewis-Jones MS, Finlay AY. The children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-9.
  27. Howlett S. Emotional dysfunction, child-family relationships and childhood atopic dermatitis. Br J Dermatol 1999;140(3);381-4. https://doi.org/10.1046/j.1365-2133.1999.02696.x
  28. Lapidus CS, Kerr PE. Social impact of atopic dermatitis. Med Health R I. 2001;84(9):294-5.
  29. Kim HS, Cho SH. Treatment for atopic dermatitis. J Korean Med Assoc. 2014;57(3):226-33. https://doi.org/10.5124/jkma.2014.57.3.226
  30. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812-24. https://doi.org/10.1542/peds.2007-2232
  31. Nicol NH, Boguniewicz M. Successful strategies in atopic dermatitis management. Dermatol Nurs. 2008;Suppl:3-18.
  32. Kang KH, Kim KW, Kim DH. Utilization pattern and cost of medical treatment and complementary alternative therapy in children with atopic dermatitis. Pediatr Allergy Respir Dis (Korea). 2012;22(1):27-36. https://doi.org/10.7581/pard.2012.22.1.27
  33. Wang T. Wai Tai Mi Yao. Beijing: Ren Min Wei Sheng Publishing Co. 1996:72.
  34. Yoon KY. Dongyui-imsangbangjehak. Seoul: Myungbo Publishing Co. 1985:228-9.
  35. Park HS. Imsangcheobang-gangjwa. Seoul: Daesung Publishing Co. 2000:167-71.
  36. Jeong JM. Zhongyuicheobanghaesul.imsang.eungyong. Seoul: Gyechuk Munwhasa. 1992:354-7.
  37. Yun YG. Dohaejeungbo Dongyuibangjewachubanghaesul. Seoul: Ui Sung Dang Publishing Co. 2007:730-46.
  38. Shin MG. Imsangbonchohak. Seoul: Yeong Rim Sa Publishing Co. 2002:252, 265, 341, 369, 443, 657, 678, 791.
  39. Jin YA, Shim JS, Lee CA, Yum HY, Han MY. The allergen sensitization, family history, diet pattern in atopic dermatitis under 2 years of age. Pediatr Allergy Respir Dis (Korea). 2003;13(3):180-8.
  40. Ahn SH, Seo WH, Kim SJ, Hwang SJ, Park HY, Han YS, Chung SJ, Lee HC, Ahn KM, Lee SI. Risk factors of moderate to severe atopic dermatitis in the first 6 months of life. Pediatr Allergy Respir Dis (Korea). 2005;15(3):242-9.
  41. Kim BS, Kim YY, Park JH, Kim NI, Choue RW. Effects of medical nutrition therapy on dietary quality, plasma fatty acid composition and immune parameters in atopic dermatitis patients. Korean J Community Nutr. 2008;13(1):80-90.
  42. Mailhol C, Lauwers-Cances V, Rance F, Paul C, Giordano-Labadie F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy. 2009;64(5):801-6. https://doi.org/10.1111/j.1398-9995.2008.01890.x
  43. Kim HY, Jang EY, Sim JH, Kim JH, Chung YH, Park SH, Hwang EM, Han YS, Ahn KM, Lee SI. Effects of family history on the occurrence of atopic dermatitis in infants. Pediatr Allergy Respir Dis (Korea). 2009;19(2):106-14.
  44. Kim JH. Review articles : current understanding of atopic dermatitis. Korean J Pediatr. 2004;14(1):12-3.
  45. Yun HJ, Ko WS. Clinical study of atopic dermatitis; the classification of oriental medical clinical type and treatment. J Korean Orient Med. 2001;22(2):10-21.
  46. Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol. 2003;21(3):201-14. https://doi.org/10.1016/S0738-081X(02)00365-6
  47. Park G. The revolution of atopy (The second volume). Suwon: Freehug Publisher. 2011:19-22, 172-89.
  48. Hill CJ, Rosenberg A Jr. Adverse effects from topical steroids. Cutis. 1978;21(5):624-8.
  49. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C. Cushing's syndrome after topical application of corticosteroids. Am J Dis Child. 1982;136(3):274-5.
  50. McLean CJ, Lobo RF, Brazier DJ. Cataracts glaucoma and femoral avascular necrosis caused by topical corticosteroid ointment. Lancet. 1995;345(8945):330.
  51. Bode HH. Dwarfism following long-term topical corticosteroid therapy. JAMA. 1980;244(8):813-4. https://doi.org/10.1001/jama.1980.03310080047027
  52. Queille C, Pommarede R, Saurat JH. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1984;1(3):246-53. https://doi.org/10.1111/j.1525-1470.1984.tb01124.x
  53. Kim DH, Kang KH, Kim KW, Yoo IY. Management of children with atopic dermatitis. Pediatr Allergy Respir Dis (Korea). 2008;18(2):148-57.
  54. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the european task force on atopic dermatitis. Dermatology. 1997;195(1):10-9.
  55. Kim DH, Li K, Seo SJ, Jo SJ, Yim HW, Kim CM, Kim KH, Kim DW, Kim MB, Kim JW, Ro YS, Park YL, Park CW, Lee SC, Cho SH. A survey on understanding of atopic dermatitis among korean patients. Korean J Dermatol. 2012;50(3):201-11.
  56. Cho SH. Atopic dermatitis in korean. J Korean Med Assoc. 2014;57(3):205-7. https://doi.org/10.5124/jkma.2014.57.3.205
  57. Lee JH, Kim KH, Kim MN, Kim JW, Ro YS, Park YL, Park CW, Lee KH, Lee AY, Cho SH, Choi JH. Report from ADRG: the treatment guideline of korean atopic dermatitis. Korean J Dermatol. 2006;44(8):907-13.

피인용 문헌

  1. 아토피 피부염의 한의학적 치료에 대한 연구 동향 -대한한방소아과학회지를 중심으로- vol.31, pp.1, 2014, https://doi.org/10.7778/jpkm.2017.31.1.025